Opening Remarks

• Ken Tindall, Ph.D., Senior Vice President, Science and Business Development, North Carolina Biotechnology Center.
• Karen Hoffman, President, NCABR.
• Bill Leinweber, Vice President, Research!America.

Panel I

• Remarks and Introductions
  Panel Moderator: Tom Linden, M.D., Director, Medical Journalism Program; GlaxoWellcome Distinguished Professor of Medical Journalism, The University of North Carolina at Chapel Hill School of Journalism and Mass Communication.
• The History of Cloning: Fact & Fiction
  Kent E. Vrana, Ph.D., Professor and Director of Graduate Studies, Department of Physiology and Pharmacology, Wake Forest University School of Medicine.
• Therapeutic vs. Reproductive Cloning
  Randy L. Jirtle, Ph.D., Director, Division of Radiation and Molecular Oncology Research; Professor of Radiation Oncology; Associate Professor of Pathology, Duke University Medical Center.
• Audience Discussion

Panel II

• Introductions
  Panel Moderator: Tom Linden, M.D.
• Reproductive Cloning in Animals
  John Vandenbergh, Ph.D., Chairman, National Academy of Science Committee on "Defining Science-Based Concerns Associated with the Products of Animal Biotechnology;" Professor, Department of Zoology, North Carolina State University.
• Ethical and Social Consideration about Cloning
  Larry Churchill, Ph.D., Professor of Social Medicine, The University of North Carolina at Chapel Hill School of Medicine.
• Audience Discussion

Closing Remarks
John F. Burness, Senior Vice President, Public and Government Relations, Duke University.

Adjourn